Milestone Pharmaceuticals Inc.
MIST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1,000 | $5,000 | $15,000 |
| % Growth | -100% | -80% | -66.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1,000 | $5,000 | $15,000 |
| % Margin | – | 100% | 100% | 100% |
| R&D Expenses | $14,357 | $31,052 | $39,829 | $38,671 |
| G&A Expenses | $16,742 | $15,932 | $15,718 | $12,399 |
| SG&A Expenses | $27,745 | $31,046 | $24,813 | $19,402 |
| Sales & Mktg Exp. | $11,003 | $15,114 | $9,095 | $7,003 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42,102 | $62,098 | $64,642 | $58,073 |
| Operating Income | -$42,102 | -$61,098 | -$59,642 | -$43,073 |
| % Margin | – | -6,109.8% | -1,192.8% | -287.2% |
| Other Income/Exp. Net | $583 | $1,413 | $1,254 | $220 |
| Pre-Tax Income | -$41,519 | -$59,685 | -$58,388 | -$42,853 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$41,519 | -$59,685 | -$58,388 | -$42,853 |
| % Margin | – | -5,968.5% | -1,167.8% | -285.7% |
| EPS | -0.67 | -1.39 | -1.35 | -1.02 |
| % Growth | 51.8% | -3% | -32.4% | – |
| EPS Diluted | -0.67 | -1.39 | -1.35 | -1.02 |
| Weighted Avg Shares Out | 62,211 | 42,956 | 42,450 | 41,834 |
| Weighted Avg Shares Out Dil | 62,211 | 42,956 | 42,450 | 41,834 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,164 | $3,967 | $1,254 | $220 |
| Interest Expense | -$3,581 | $2,554 | $0 | $0 |
| Depreciation & Amortization | $105 | $92 | $89 | $93 |
| EBITDA | -$37,833 | -$57,039 | -$58,299 | -$42,980 |
| % Margin | – | -5,703.9% | -1,166% | -286.5% |